Delivery Order SPE2DB22D3004-SPE2DB26FQ79A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,622.55 to AmerisourceBergen Drug Corp for the supply of Lamictal 200 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lamictal 100 mg tablets (quantity 100) with a ceiling value of $27,252.70. This is a firm fixed price delivery order with no set-aside designation, executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.16 to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 11, 2025, with completion scheduled for August 12, 2025. This delivery order was awarded on a firm fixed price basis without set-aside designation, indicating competitive award to this established pharmaceutical vendor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal 25 mg tablets (100-count units) valued at $19,868.41 on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 13, 2025, with a ceiling value of $2,273.15. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,579.11 to AmerisourceBergen Drug Corp for the supply of Lamictal 25 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal (lamotrigine) 25 mg tablets in quantities of 100 units. This competitive, non-set-aside contract was executed on September 23, 2025, with a firm fixed price ceiling value of $3,822.90 and an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on July 28, 2025, to supply 60 tablets of Lamictal 150 mg with a ceiling value of $12,599.98. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 29, 2025. The contract serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $3,318.84, is for the supply of 100 tablet bottles of the prescription drug Lamictal (Lamotrigine) 25 milligrams. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a...
- This is a $2,587.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lamictal 200 mg tablets. The order is part of a larger $999,999,999 Indefinite Delivery Contract the DLA Troop Support Medical has with AmerisourceBergen for delivering a range of medical commodities to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ79ADelivery Order
The Defense Logistics Agency (DLA) awarded a $1,757.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 200 mg, with an ultimate completion date of October 30, 2025. This non-set-aside competitive award was issued on October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this delivery order under its broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare systems. Lamictal (lamotrigine) is a neurological treatment commonly used in defense health programs, and this transaction exemplifies AmerisourceBergen's role as a primary vendor for the DLA's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries across multiple therapeutic domains, demonstrating its capability to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet global military medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/29/25 |